Clinical Trial Modernization
New resolutions are often the focus in January, giving us the opportunity to make progress in a way that's meaningful to us. At ActiGraph, our resolution (our mission) remains the same - pioneering the digital transformation of clinical research - but we are excited to take a meaningful new step to progress our mission.
This month, we announced that the Biofourmis Connect life science platform is now part of the ActiGraph digital health technology ecosystem! This enables ActiGraph to deliver the industry’s most comprehensive and trusted digital health solution to our clients, supporting a wide range of clinical use cases. We're confident that the streamlined collection of continuous, high precision data centered on the patient can modernize clinical trials with AI-powered insights and more effective clinical evidence generation.
Wearable maker ActiGraph acquires assets from Biofourmis to boost clinical trial offerings
In this STAT News interview, Mario Aguilar talks with Jeremy Wyatt and Christine Cong Guo about how the acquisition expands our offerings in best-in-class digital health tools for clinical trials.
New Digital Health Tool for Cough Monitoring is Available
The new digital health solution for cough detection using the ActiGraph LEAP is now available! ActiGraph is excited to partner with Hyfe to offer a combined solution that allows researchers to leverage Hyfe’s validated cough detection algorithms alongside ActiGraph’s industry leading digital measures for physical activity, sleep, and vital signs to monitor this cardinal symptom in conditions such as COPD, Idiopathic Pulmonary Fibrosis, and Asthma.
ADDS 2025 - Last Chance to Register!
The ActiGraph Digital Data Summit is February 10-12, 2025! You can view the updated ADDS 2025 Agenda, including all speakers, conference activities, and presentation topics, such as -
We're excited to share 2 new case studies of how high precision, continuous digital data can help us modernize clinical outcome measures with real-world insights, advancing drug development efforts -
领英推荐
Wearable DHTs Demonstrate Meaningful Treatment Benefits for Patients with Cancer Cachexia
Read our new case study of how wearable DHTs demonstrated a meaningful treatment benefit for patients in Pfizer's recent Phase 2 Cancer Cachexia clinical trial, providing objective evidence on the real-world impact of this treatment on patients’ everyday lives.
Accelerating DHT Research and Drug Development with Open-source Big Data from Population Studies
Learn about the large-scale epidemiological study, National Health and Nutrition Examination Survey (NHANES), and how to access and leverage digital health data collected during this study, including a detailed case study using NHANES data to develop a framework to determine an appropriate digital endpoint for measuring physical activity in patients with diabetes.
Upcoming Conferences | Meet the ActiGraph Team
SCOPE 2025 | February 3-6
Orlando, FL. Visit Booth #1034 to discuss digital measures in clinical trials with John Bailey , Sarah Bell , Michael Philcock , and Sean Smith , and don't miss Digital Biomarkers in Oncology Studies series at 3:20 PM on Tuesday, February 4, chaired by Adam Butler .
The ActiGraph Digital Data Summit 2025 | February 10-12
Pensacola Beach, FL. Connect with leaders in the digital health field and learn about the latest research, tools, and techniques supporting broader adoption of DHTs in clinical research. REGISTER TODAY!
Want to stay up to date on the latest in Digital Health Technology from ActiGraph? Subscribe to our mailing list! CLICK HERE